Clinical Trial Update: A Study of AK112 in Advanced Malignant Tumors [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 1/2 study evaluating AK112 in patients with advanced cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AK112

Snippet

Sponsor: Akeso | Conditions: Advanced Malignant Tumors | Phase 1, Phase 2 | Status: COMPLETED